VistaGen Therapeutics appoints Maggie FitzPatrick to its Board of Directors

– USA, CA –  VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to developing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression, and other central nervous system disorders, today announced the appointment of Maggie FitzPatrick to its Board of Directors, replacing Dr.…